Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | group enriched outside the brain (fallopian secretory cells) | 0.10 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 2 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 2 Parkinson's papers of 1,042 | 0.85 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 10472
Sealed predictions
- CCL7 in dopamine neurons, braak+0.26 (p 0.499) → +0.25 (p 0.517)receipt 10480
Swarm cases
receipt 10480: CCL7 in dopamine neurons, braak
- power
- full sample +0.21 (p 0.406, n 18), 95% CI -0.29 to +0.62. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.20 (p 0.416, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.02 (p 0.935, n 18). could be the mix.
- skeptic
- leave-one-out range +0.11 to +0.35, sign flips 0; without severely affected donors +0.21 (p 0.406, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CCL7 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts